Prafull Ghatage

8PUBLICATIONS
157CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Aug 09, 2024
Narrative review on the evolving role of HER2/neu targeting in uterine serous cancers.

Aarthi S Jayraj, Salamatu Abdul-Aziz, Anisa Mburu

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|May 01, 2023
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.

Oliver Dorigo, Amit M Oza, Tanja Pejovic

|Nov 03, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.

Ashley Weir, Eun-Young Kang, Nicola S Meagher

Pageof 2

Frequent Collaborators

4 joint publications

Susan Ramus

4 joint publications

James D Brenton

4 joint publications

Anna DeFazio

4 joint publications

Peter Fasching